Literature DB >> 23835024

Patients' knowledge about paracetamol (acetaminophen): a study in a French hospital emergency department.

Y Boudjemai1, P Mbida, V Potinet-Pagliaroli, F Géffard, G Leboucher, J-L Brazier, B Allenet, B Charpiat.   

Abstract

UNLABELLED: Paracetamol is the most widely used analgesic and antipyretic drug. In France, little is known concerning patients' knowledge and beliefs about paracetamol.
OBJECTIVE: To determine how much outpatients attending an emergency department know about paracetamol.
METHOD: A semi-structured questionnaire was applied to patients consulting for non-severe medical or traumatic conditions.
RESULTS: Thirty-three (45%) of 73 participating patients knew that paracetamol was the active ingredient of the medication they used to reduce pain and/or fever. Three patients thought 2g was the maximum recommended single dose; 25% thought that a delay between two doses ≤ 3 hours was recommended and 15% thought the maximum daily dose was > 4 g. While 8% cited liver toxicity as a side effect, 38% did not believe an excessive dose could be fatal. Two patients correctly answered all questions and five gave no correct answer. DISCUSSION: Outpatients attending an emergency department (ED) have poor knowledge about paracetamol. This situation is disturbing and our results may serve as an eye opener to healthcare professionals. They emphasize the need for research programs with the following objectives: a) to determine the actual content of the message delivered by healthcare professionals; b) to study conditions under which this message is issued; c) to analyze how patients understand key messages and what their behavioral response is.
CONCLUSION: In ED patients, the level of knowledge about paracetamol is insufficient to ensure its safe use in ambulatory care. Further studies are needed to determine the causes and to permit better patient education.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Connaissance en santé; Emergency department; Enquête; Health knowledge; Hepatotoxicity; Hépatotoxicité; Paracetamol; Paracétamol; Patients; Service d’urgences; Surveys

Mesh:

Substances:

Year:  2013        PMID: 23835024     DOI: 10.1016/j.pharma.2013.03.001

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN: 0003-4509


  3 in total

1.  Limited Knowledge of Acetaminophen in Patients with Liver Disease.

Authors:  Sammy Saab; Peter G Konyn; Matthew R Viramontes; Melissa A Jimenez; Jonathan F Grotts; Wally Hamidzadah; Veronica P Dang; Negin L Esmailzadeh; Gina Choi; Francisco A Durazo; Mohamed M El-Kabany; Steven-Huy B Han; Myron J Tong
Journal:  J Clin Transl Hepatol       Date:  2016-12-27

2.  Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic.

Authors:  Enas M A Mostafa; Ayat M Tawfik; Khadiga M Abd-Elrahman
Journal:  Toxicol Rep       Date:  2022-03-29

3.  Rational use of paracetamol among out-patients in a Bhutanese district hospital bordering India: a cross-sectional study.

Authors:  Thinley Dorji; Kinley Gyeltshen; Krit Pongpirul
Journal:  BMC Res Notes       Date:  2018-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.